OSAM
KRYS icon

O'Shaughnessy Asset Management’s Krystal Biotech KRYS Stock Holding History

O'Shaughnessy Asset Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$471K Sell
1,823
-600
-25% -$160K ﹤0.01% 1561
2025
Q4 		$597K Buy
2,423
+938
+63% +$197K ﹤0.01% 1400
2025
Q3 		$262K Buy
+1,485
New +$222K ﹤0.01% 1818
2025
Q2 		– Sell
-1,538
Closed -$277K – 2454
2025
Q1 		$277K Buy
+1,538
New +$259K ﹤0.01% 1628
2024
Q4 		– Sell
-1,425
Closed -$256K – 2246
2024
Q3 		$256K Buy
+1,425
New +$275K ﹤0.01% 1551

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return